The selective advantage of α1-antitrypsin deficiency

被引:59
|
作者
Lomas, DA [1 ]
机构
[1] Univ Cambridge, Cambridge Inst Med Res, Dept Med, Cambridge CB2 2XY, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
alpha-antitrypsin; inflammation; polymers; serpinopathies; serpins;
D O I
10.1164/rccm.200511-1797PP
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The S- and Z-deficiency alleles of alpha(1)-antitrypsin are found in more than 20% of some white populations. This high gene frequency suggests that these mutations confer a selective advantage, but the biologic mechanism of this has remained obscure. It is now well recognized that the S and Z alleles result in a conformational transition within the oil-antitrypsin molecule and the formation of polymers that are retained within the endoplasmic reticulum of hepatocytes. Polymers of mutant alpha(1)-antitrypsin can also form within the alveoli and small airways of the lung where they may drive the inflammation that underlies emphysema in individuals with a,antitrypsin deficiency. This local production of polymers by mutant S and Z alpha(1)-antitrypsin may have also provided protection against infectious disease in the preantibiotic era by focusing and amplifying the inflammatory response to limit invasive respiratory and gastrointestinal infection. It is only since the discovery of antibiotics, the widespread adoption of smoking, and increased longevity that these protective, proinflammatory properties of alpha(1)-antitrypsin mutants have become detrimental to cause the emphysema and systemic inflammatory diseases associated with of alpha(1)-antitrypsin deficiency.
引用
收藏
页码:1072 / 1077
页数:6
相关论文
共 50 条
  • [21] Alpha 1-antitrypsin deficiency
    Mornex, J. -F.
    REVUE DES MALADIES RESPIRATOIRES, 2022, 39 (08) : 698 - 707
  • [22] α1-Antitrypsin Polymerizes in Alveolar Macrophages of Smokers With and Without α1-Antitrypsin Deficiency
    Bazzan, Erica
    Tine, Mariaenrica
    Biondini, Davide
    Benetti, Riccardo
    Baraldo, Simonetta
    Turato, Graziella
    Fagiuoli, Stefano
    Sonzogni, Aurelio
    Rigobello, Chiara
    Rea, Federico
    Calabrese, Fiorella
    Foschino-Barbaro, Maria Pia
    Miranda, Elena
    Lomas, David A.
    Saetta, Marina
    Cosio, Manuel G.
    CHEST, 2018, 154 (03) : 607 - 616
  • [23] Compelling evidence for the efficacy of α1-antitrypsin augmentation treatment for α1-antitrypsin deficiency
    Crystal, Ronald G.
    LANCET RESPIRATORY MEDICINE, 2017, 5 (01): : 7 - 8
  • [24] Enigma of α1-antitrypsin:: α1-antitrypsin deficiency reveals a puzzling physiological function
    Nukiwa, T
    INTERNAL MEDICINE, 2001, 40 (04) : 271 - 272
  • [25] α1-Antitrypsin deficiency: A pediatric perspective
    Schwerk N.
    Kardorff R.
    Der Pneumologe, 2010, 7 (5): : 365 - 369
  • [26] Successful α1-antitrypsin replacement therapy in a patient with α1-antitrypsin deficiency and granulomatosis with polyangiitis
    Hernandez Perez, Jose Maria
    Garcia, Sergio Fumero
    Pio, Alberto Alvarez
    RHEUMATOLOGY, 2013, 52 (04) : 755 - 757
  • [27] Augmentation therapy in α1-antitrypsin deficiency
    Burdon, JGW
    Brenton, S
    Ayad, M
    Knight, K
    CHEST, 2001, 120 (02) : 687 - 687
  • [28] α1-antitrypsin deficiency and Pi typing
    Barlow, Ian
    Sewell, W. A. Carrock
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (03) : 658 - 658
  • [29] Augmentation therapy for α1-antitrypsin deficiency
    Juvelekian, GS
    Stoller, JK
    DRUGS, 2004, 64 (16) : 1743 - 1756
  • [30] Pneumothorax Associated with α1-Antitrypsin Deficiency
    Kanazawa, Shigenori
    Kinoshita, Yoshimi
    Nakagawa, Yuki
    Akai, Miku
    Ookura, Mari
    Uemura, Shinobu
    Yamaguchi, Kazuyuki
    Nomura, Shosaku
    INTERNAL MEDICINE, 2009, 48 (05) : 387 - 388